Sumitomo Pharma America, Inc.

MA · United States · Reporting entity ID 100001316929

Total reported 2019–2025

$134.6M

#76 of 2,960 reporting companies — 0.2% of all reported industry payments

$13.9M in general payments across 312,682 records, plus $120.8M in research funding across 36,747 records.

How it breaks down

General payments $13,859,698

Research funding $120,753,956

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.